click on circles to display study description...
Aspirin (n=7351) vs. standard of care (n=7541)
randomized controlled trial
Aspirin
Usual care plus 150mg aspirin once per day by mouth (or nasogastric tube) or by rectum until discharge.
Usual care
As a platform trial, and in a factorial design, patients could be simultaneously randomly assigned to the following other treatment groups: azithromycin, colchicine,or dimethyl fumarate versus usual care; convalescent plasma or casirivimab and imdevimab versus usual care; and baricitinib versus usual care. Until Jan 24, 2021, the trial also allowed asubsequent randomisation for patients with progressive COVID-19 (evidence of hypoxia and a hyperinflammatory state) to tocilizumab versus usual care. 210 patients (3%) allocated to usual care received at least one dose of aspirin.
COVID 19 hospitalized
Open-label.
177 hospitals in the UK, 2 hospitals in Indonesia, and 2 hospitals in Nepal.
powered by vis.js Network
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -
An extraction panel is open